Level | Rating | Percentiles | |
---|---|---|---|
Diamond | 900+ | 99th | |
Platinum | 800-899 | 95th-98th | |
Gold | 700-799 | 81st-94th | |
Silver | 600-699 | 60th-80th | |
Bronze | 0-599 | 0-59th |
Rankings | Fantasy | Time | Field Goals | Free Throws | 3PT | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pos | Players | Action | GP* | Opp | Status | Pre-Season | Current | % Started | % Rostered | MPG | FGM/A* | FG% | FTM/A* | FT% | 3PTM | PTS | REB | AST | ST | BLK | TO | ||
PG | Tyus JonesWAS - PG
| - | @BOS | 62 | 531 | 30% | 73% | - | -/- | - | -/- | - | - | - | - | - | - | - | - | ||||
SG | Ben SimmonsBKN - PG,SG,PF
| - | @PHI | 189 | 559 | 7% | 26% | - | -/- | - | -/- | - | - | - | - | - | - | - | - | ||||
G | Devin BookerPHX - PG,SG,SF
| - | @MIN | 31 | 19 | 79% | 99% | - | -/- | - | -/- | - | - | - | - | - | - | - | - | ||||
SF | Zach LaVineCHI - SG,SF
| - | @NYK | 258 | 511 | 20% | 45% | - | -/- | - | -/- | - | - | - | - | - | - | - | - | ||||
PF | Grant WilliamsCHA - PF,C
| - | @CLE | 132 | 155 | 24% | 34% | - | -/- | - | -/- | - | - | - | - | - | - | - | - | ||||
F | Dillon BrooksHOU - SG,SF
| - | @LAC | 165 | 206 | 21% | 32% | - | -/- | - | -/- | - | - | - | - | - | - | - | - | ||||
C | Rudy GobertMIN - C
| - | PHX | 45 | 47 | 85% | 96% | - | -/- | - | -/- | - | - | - | - | - | - | - | - | ||||
C | Evan MobleyCLE - PF,C
| - | CHA | 26 | 55 | 74% | 97% | - | -/- | - | -/- | - | - | - | - | - | - | - | - | ||||
Util | Shaedon SharpePOR - SG,SF
| - | @SAC | 211 | 571 | 11% | 35% | - | -/- | - | -/- | - | - | - | - | - | - | - | - | ||||
Util | Klay ThompsonGSW - SG,SF
| - | UTA | 88 | 40 | 72% | 88% | - | -/- | - | -/- | - | - | - | - | - | - | - | - | ||||
BN | Naz ReidMIN - PF,C
| - | PHX | 110 | 75 | 69% | 80% | - | -/- | - | -/- | - | - | - | - | - | - | - | - | ||||
BN | Paul GeorgeLAC - SG,SF,PF
| - | HOU | 22 | 6 | 91% | 99% | - | -/- | - | -/- | - | - | - | - | - | - | - | - | ||||
BN | Giannis AntetokounmpoMIL - PF,C
| - | @ORL | 7 | 27 | 77% | 98% | - | -/- | - | -/- | - | - | - | - | - | - | - | - |